DK0457336T3 - Ny anvendelse af 4-carbamoyl-1-beta-D-ribofuranosylimidazolium-5-olat - Google Patents

Ny anvendelse af 4-carbamoyl-1-beta-D-ribofuranosylimidazolium-5-olat

Info

Publication number
DK0457336T3
DK0457336T3 DK91107985.3T DK91107985T DK0457336T3 DK 0457336 T3 DK0457336 T3 DK 0457336T3 DK 91107985 T DK91107985 T DK 91107985T DK 0457336 T3 DK0457336 T3 DK 0457336T3
Authority
DK
Denmark
Prior art keywords
olate
carbamoyl
beta
ribofuranosylimidazolium
new use
Prior art date
Application number
DK91107985.3T
Other languages
English (en)
Inventor
Takahiko Dr Saida
Kyoko Dr Saida
Original Assignee
Asahi Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Ind filed Critical Asahi Chemical Ind
Application granted granted Critical
Publication of DK0457336T3 publication Critical patent/DK0457336T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK91107985.3T 1990-05-17 1991-05-16 Ny anvendelse af 4-carbamoyl-1-beta-D-ribofuranosylimidazolium-5-olat DK0457336T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2127529A JPH0649650B2 (ja) 1990-05-17 1990-05-17 ４―カルバモイル―１―β―Ｄ―リボフラノシル―イミダゾリウム―５―オレイトを有効成分とする用途

Publications (1)

Publication Number Publication Date
DK0457336T3 true DK0457336T3 (da) 1995-08-07

Family

ID=14962276

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91107985.3T DK0457336T3 (da) 1990-05-17 1991-05-16 Ny anvendelse af 4-carbamoyl-1-beta-D-ribofuranosylimidazolium-5-olat

Country Status (9)

Country Link
US (1) US5472947A (da)
EP (1) EP0457336B1 (da)
JP (1) JPH0649650B2 (da)
AT (1) ATE122889T1 (da)
AU (1) AU631989B2 (da)
CA (1) CA2042752A1 (da)
DE (1) DE69109933T2 (da)
DK (1) DK0457336T3 (da)
NZ (1) NZ238163A (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06116151A (ja) * 1991-08-06 1994-04-26 Asahi Chem Ind Co Ltd 増殖性皮膚疾患治療用組成物
WO2004012746A2 (en) * 2002-08-02 2004-02-12 The Regents Of The University Of California New uses for inhibitors of inosine monophosphate dehydrogenase

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4912720B2 (da) * 1971-11-15 1974-03-26
US3888843A (en) * 1973-06-12 1975-06-10 Toyo Jozo Kk 4-carbamoyl-1-' -d-ribofuranosylimidazolium-5-olate
JPS5652038B2 (da) * 1974-03-09 1981-12-09
JPS5647196B2 (da) * 1974-03-09 1981-11-07
JPS511693A (en) * 1974-06-21 1976-01-08 Toyo Jozo Kk 44 karubamoiru 11 beetaa dd ribofuranoshiiru imidazoriumu 55 oreitonoseizoho
US3960836A (en) * 1974-07-22 1976-06-01 Eli Lilly And Company Acylated derivatives of pyrazofurin and process for their preparation
JPS57156418A (en) * 1981-03-19 1982-09-27 Sumitomo Chem Co Ltd Carcinostatic
JPS60142998A (ja) * 1983-12-28 1985-07-29 Toyo Jozo Co Ltd ５’−デオキシブレデイニンおよびその製造法
JPS60193997A (ja) * 1984-03-14 1985-10-02 Sumitomo Chem Co Ltd 新規シアノイミダゾ−ルリボヌクレオシド誘導体およびその製造法

Also Published As

Publication number Publication date
AU631989B2 (en) 1992-12-10
EP0457336A3 (en) 1992-03-04
US5472947A (en) 1995-12-05
DE69109933D1 (de) 1995-06-29
JPH0649650B2 (ja) 1994-06-29
EP0457336A2 (en) 1991-11-21
ATE122889T1 (de) 1995-06-15
NZ238163A (en) 1997-06-24
JPH0421632A (ja) 1992-01-24
EP0457336B1 (en) 1995-05-24
CA2042752A1 (en) 1991-11-18
DE69109933T2 (de) 1996-02-08
AU7703491A (en) 1991-11-21

Similar Documents

Publication Publication Date Title
LU91378I2 (en) Melatonin circadin
ATE76747T1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
IE790756L (en) Cerebral therapeutic agent
DK0565549T3 (da) Anvendelse af 1,3-oxathiolannucleosidanaloger til fremstilling af et præparat til behandling af hepatitis B
DK0615754T3 (da) Faste flupertinholdige orale administrationsformer med kontrolleret frigivelse af den aktive forbindelse
MY106231A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones.
EA199800160A1 (ru) Фармацевтическая композиция для лечения сердечно-сосудистых заболеваний, содержащая 3-(2,2,2-триметилгидразиний)пропионат и гамма-бутиробетаин
EP0328924A3 (en) Thienotriazolodiazepine compounds and pharmaceutical uses thereof
AU1488392A (en) Pharmeceutical composition for the treatment of autoimmune diseases
GR3025518T3 (en) Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus
DK0457336T3 (da) Ny anvendelse af 4-carbamoyl-1-beta-D-ribofuranosylimidazolium-5-olat
EP0476711A3 (en) Use of 5-fluorouracil for the treatment of AIDS
EP0270046A3 (en) Pharmaceutical composition for treatment of cataract
TW349864B (en) Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
CA2065889A1 (en) Increasing the choroidal blood flow
IL126795A (en) Pharmaceutical compositions for the treatment of substance abuse disorders comprising pyridyl- and pyrimidyl-piperazines
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
IL98199A0 (en) Pharmaceutical compositions containing a derivative of substituted-l-valyl-l-prolinamide
EP0353910A3 (en) Human interferon-gamma, process for preparing said human interferon-gamma, and its use
IL87867A0 (en) Preparation of pharmaceutical compositions containing a 2,6-diamino-pyridine derivatives
SG4595G (en) Use of 2-oxo-imidazolidine derivatives in the prophylaxis and treatment of heart failure
CA2099667A1 (en) Agent for treating hepatic diseases
ATE316373T1 (de) Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn
PH22984A (en) 2,4,6-tris-tertiary-butylamino-1,3,5-triazine for the prophylaxis and treatment of epilepsy and anxiety states, the use of this compound for the preparation of medicament and medicaments base on this compound
EP0272849A3 (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases